You just read:

Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology

News provided by

Refuge Biotechnologies, Inc.

May 02, 2018, 00:01 ET